Markets:

Overview

News

Currencies

International

Treasuries

PMV Pharmaceuticals, Inc. - Common Stock (NQ:PMVP)

1.075 -0.005 (-0.46%)

Streaming Delayed Price Updated: 10:50 AM EST, Feb 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about PMV Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 Next >

CarMax Stock Down 47% This Past Year, But One Fund Is Betting $6 Million on a Turnaround ↗

February 03, 2026

CarMax runs a nationwide network of used car stores and digital channels, offering multi-channel sales and financing to U.S. consumers.

Via The Motley Fool

Topics Regulatory Compliance

Alumis Stock Has Rallied 250% This Past Year. One Fund Sold Its $5 Million Stake Last Quarter. ↗

February 03, 2026

This clinical-stage biotech develops therapies targeting autoimmune and neuroinflammatory diseases with a focus on TYK2 inhibition.

Via The Motley Fool

Small-Cap PMV Pharmaceuticals Cancer Drug Shows Confirmed Responses In 8 Tumor Types ↗

September 10, 2025

PMV Pharma's Phase 2 trial shows 33% response in TP53 Y220C-mutated tumors, with ovarian cancer achieving a 43% response rate in interim results.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 10, 2025

Via Benzinga

Recap: PMV Pharma Q3 Earnings ↗

November 09, 2023

Via Benzinga

The Latest Analyst Ratings for PMV Pharma ↗

May 17, 2023

Via Benzinga

PMV Pharma: Q1 Earnings Insights ↗

May 10, 2023

Via Benzinga

Get insights into the top gainers and losers of Wednesday's pre-market session. ↗

September 10, 2025

As the US market prepares to open on Wednesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 10, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 25, 2025

Via Benzinga

PMV Pharmaceuticals (PMVP) Q2 Loss Jumps ↗

August 07, 2025

Via The Motley Fool

Topics Intellectual Property

PMV Pharmaceuticals Inc (NASDAQ:PMVP) Reports Q2 2025 Earnings Miss with -$0.41 EPS, Stock Shows Muted Reaction ↗

August 07, 2025

PMV Pharmaceuticals reported Q2 2025 EPS of -$0.41, slightly missing estimates. Revenue was $0.0 as expected. Stock dipped 1.3% pre-market but gained 17.8% over the past month. Focus remains on...

Via Chartmill

Topics Earnings

“Game-Changing Biotech Companies Making Waves: INBS, PMVP, TPST, OMGA, MRSN”

August 16, 2024

Via AB Newswire

PMVP Stock Earnings: PMV Pharma Beats EPS for Q2 2024 ↗

August 08, 2024

PMVP stock results show that PMV Pharma beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator

May 29, 2024

From Foundation Medicine

Via Business Wire

PMVP Stock Earnings: PMV Pharma Beats EPS for Q1 2024 ↗

May 09, 2024

PMVP stock results show that PMV Pharma beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 13, 2023

Via Benzinga

Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

October 13, 2023

Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc.

Via Benzinga

Precision Oncology PMV Pharmaceuticals Reveals Early Data From Cancer Study In Pretreated Patients ↗

October 12, 2023

PMV Pharmaceuticals Inc (NASDAQ: PMVP) announced updated Phase 1 results from its ongoing Phase 1/2 PYNNACLE trial that showed PC14586 achieved efficacy in heavily pretreated patients across multiple...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 12, 2023

Via Benzinga

Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

September 22, 2023

Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search algorithm to boost the performance and efficiency of research institutions.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 09, 2023

Via Benzinga

Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session ↗

August 09, 2023

Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss.

Via Benzinga

Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday ↗

August 09, 2023

U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Stocks That Hit 52-Week Lows On Friday ↗

February 24, 2023

On Friday, 135 companies reached new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

January 09, 2023

Companies That Fell Through 52-Week Lows Monday During Monday's morning trading, 14 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

December 12, 2022

Monday saw 196 companies set new 52-week lows.

Via Benzinga

Target To Rally 29%? Plus This Analyst Predicts $245 For IQVIA Holdings ↗

November 17, 2022

Piper Sandler boosted the price target on Target Corporation (NYSE: TGT) from $190 to $200. Target shares fell 13.1% to close at $155.47 on Wednesday.

Via Benzinga

PMV Pharma, Merck Ink Clinical Trial Collaboration For Combination Study In Solid Tumors ↗

July 18, 2022

Via Benzinga

79 Biggest Movers From Yesterday ↗

June 08, 2022

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday on continued strength after the FDA granted clearance for the company's pūrgo technology, classifying it...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.